GANX earnings: a negative outcome, -7.3%

On March 25, 2022, Gain Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.3% in the window around the event. It had already run +25.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.